<DOC>
	<DOCNO>NCT00043199</DOCNO>
	<brief_summary>To determine rate response duration reponse follow therapy Aroplatin subject advance colorectal cancer resistant standard therapy . Secondary objective determine safety tolerability Aroplatin therapy .</brief_summary>
	<brief_title>A Safety Effectiveness Study Aroplatin Patients With Advanced Colorectal Cancer Resistant Standard Therapies</brief_title>
	<detailed_description>Primary Objective : - To determine response rate ( RR ; complete partial response [ CR , PR ] duration therapy Aroplatin ( Liposomal NDDP , L-NDDP ) subject locally recurrent , unresectable metastatic colorectal cancer refractory 5-FU/leucovorin capecitabine , irinotecan . Secondary Objective : - To determine safety tolerability Aroplatin therapy . This single-arm , open-label phase II study . Subjects refractory 5-FU/leucovorin capecitabine , irinotecan therapy enrol . Dosing every four week individual dose escalation adjustment toxicity .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>bis-neodecanoato-1,2-diaminocyclohexaneplatinum ( II )</mesh_term>
	<criteria>Colorectal cancer , locally recurrent , unresectable metastatic disease ( AJCC ) ; Measurable disease ( RECIST criterion ) ; Cancer refractory 5FU/leucovorin capecitabine , irinotecan ; ECOG performance score 02 ; Adequate hematopoietic , liver renal function ; Adequate cardiac function ( maximum class II , NYHA ) ; Women childbearing potential must negative urine serum pregnancy test ; Signed write informed consent ; Subjects must willing follow course treatment/observation followup . Other malignancy treat within last five year , except situ cervix carcinoma nonmelanoma skin cancer ; Pregnant breast feed subject , male female subject child produce potential agree use adequate contraception treatment phase study ; Prior therapy oxaliplatin ; Known brain metastasis ; Active , uncontrolled infection serious medical illness ; Subjects may use use investigational therapy four week start protocol treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Colorectal Tumor</keyword>
	<keyword>Neoplasms , Colorectal</keyword>
	<keyword>Unresectable</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Refractory</keyword>
</DOC>